Page 51
To place an order, go to
or call (800) 633-1106
since 1911
• Willner Chemists •
the nutritional supplement professionals
Supplementing with Kyolic Aged Garlic
Extract can halt-and even reverse-the
accumulation of deadly low-attenuation
plaque in arteries, according to new
research in The Journal of Nutrition. The
amount of low attenuation, or “soft,”
plaque in the arteries contributes to the
development of atherosclerosis and
predicts a future acute coronary event
like a heart attack or stroke. Since
cardiovascular disease is the No.1 killer
in America, these findings provide
potentially life-saving hope for millions
of people.
The study, which was conducted at LA
BioMed and led by Matthew J. Budoff,
MD, involved 55 patients, aged 45 to
75, that had been diagnosed with
metabolic syndrome. People with this
condition are at an increased risk of
cardiovascular disease. All of the
participants were screened at the
beginning of the study to measure total
amount of arterial plaque as well as
calcium deposits, non-calcified plaque,
and low attenuation plaque. The
screening was done using Cardiac
Computed Tomography Angiography
(CCTA), an innovative imaging technique
that can accurately measure both
calcium deposits and plaque buildup in
the arteries.
After the initial screening, each of the
participants was given either 2,400 mg
of Kyolic Aged Garlic Extract or a
placebo each day for 12 months. At the
end of the study, the subjects were
screened again using CCTA. The Aged
Garlic Extract slowed the accumulation
of plaque by as much as 80 percent,
reduced the amount of soft plaque, and
showed a marked reversal of low-
attenuation plaque among those taking
the supplement.
Earlier studies have found that Kyolic
Aged Garlic Extract, combined with
other nutrients, reduces the progression
of arterial calcification and decreases
lipoprotein-associated phospholipase A2
(Lp-PLA2). It also reduces oxidation,
improves the elasticity of the arteries,
and lowers both cholesterol and blood
pressure. This new research simply adds
to the growing body of evidence
verifying Kyolic Aged Garlic Extract’s
significant cardiovascular benefits.
“We have completed four randomized
studies, and they have led us to
conclude that Aged Garlic Extract can
help slow the progression of
atherosclerosis and reverse the early
stages of heart disease,” said Budoff.
“This study provides further evidence of
Kyolic Aged Garlic Extract’s
cardiovascular benefits.”
The subject of more than 750 peer-
reviewed studies, Kyolic Aged Garlic
Extract undergoes an extensive two-year
proprietary process that
concentrates the active
beneficial compounds in
organically-grown garlic.
This includes the potent
antioxidant S-allyl cysteine
and other sulfur- rich
amino acids responsible for
Kyolic’s wide-ranging
health benefits, especially
for the cardiovascular
system. The process also
eliminates the odor-
causing components
naturally found in the
herb.
“This clinical study is very
important because Kyolic
Aged Garlic Extract has shown
reproducible effects for slowing the
progression of coronary artery calcium,
improving blood vessel function, and
reducing inflammatory and oxidative
stress biomarkers,” says Masaki
Matsushita, Director of Research and
Development at Wakunaga, the maker
of Kyolic Aged Garlic Extract. “This
clinical study will be useful, not only in
preventing the accumulation of low-
attenuation plaque, but also potentially
reversing it’s buildup in those at risk of a
future cardiovascular event.”
Note 1:
To see a copy of the actual
study, please click this link:
_
HeartDisease_02092016.pdf]
Note 2:
To see a full listing of Kyolic
Aged Garlic Supplements and the
Willner Chemists discount prices, please
click this link:
?
mfr=kyolic]
Note 3:
To see a listing of the Kyolic
Aged Garlic Supplements designed
specifically for those with various types of
cardiovascular disease, click on this link:
d=17804,17806,17818,44845,43218,5
6546,51734
Note 4:
For more information on aged
garlic, and Kyolic products, go to
References:
Aged Garlic Extract Reduces Low
Attenuation Plaque in Coronary Arteries
of Patients with Metabolic Syndrome in a
Prospective Randomized Double-Blind
Study’ Suguru Matsumoto,4 Rine
Nakanishi,4 Dong Li,4 Anas Alani,4
Panteha Rezaeian,4 Sach Prabhu,5 Jeby
Abraham,4 Michael A Fahmy,4
Christopher Dailing,4 Ferdinand Flores,4
Sajad Hamal,4 Alexander Broersen,6
Pieter H Kitslaar,6,7 and Matthew J
Budoff4. The Journal of Nutrition. First
published ahead of print January 13,
2016 as doi: 10.3945/jn.114.202424.
(See link above)
Matthew Budoff, MD, FACC, FAHA, is
an associate professor of medicine at the
David Geffen School of Medicine at
UCLA and is the Director of Cardiac CT
at Harbor-UCLA Medical Center in
Torrance, CA. A Fellow of the American
College of Cardiology and the American
Heart Association , Dr. Budoff has
published more than 200 scientific
papers on the topic of cardiology. Much
of this research has been conducted
using the electron beam CT and multi-
detector CT. He is currently the
President of the Society of
Atherosclerosis Imaging and Prevention
and was founding board member of the
Society of Cardiovascular CT. Dr. Budoff
is board certified in internal medicine
and cardiology.
About LA BioMed was founded in 1952
. Today it is one of the country’s leading
nonprofit independent biomedical
research institutes. It has approximately
100 principal researchers conducting
studies into improved diagnostics and
treatments for cancer, inherited diseases,
infectious diseases, illnesses caused by
environmental factors and more. It also
educates young scientists and provides
community services, including prenatal
counseling and childhood nutrition
programs. LA BioMed is academically
affiliated with the David Geffen School
of Medicine at UCLA and located on the
campus of Harbor-UCLA Medical
Center. For more information, please
visit
About Wakunaga of America: Since its
establishment in 1972, the Wakunaga
group of companies has played a uniq
ue role in promoting consumer health
worldwide through the research,
development, manufacturing and
marketing of high quality medicinal
herbs. The corporate philosophy of
Wakunaga centers around a
commitment to research and a mission
to serve public health. This mission is
accomplished by providing products of
the highest quality, which are supported
by truthful science and accompanied by
helpful consumer information.
Willner Chemists carries the full line of
Kyolic supplements; Our pharmacists
and nutritionists are always available
to answer your questions.
Garlic Extract Reverses Heart Disease
New UCLA Clinical Study Shows Kyolic Aged Garlic Extract
Reverses Heart Disease
Reference Library • Radio Program Archives • Product Listings & Prices • Sale Discounts • Convenient Ordering • Digital Catalog
The Willner Chemists web site:
Here’s What I Think!
Don Goldberg’s Blog . . . comments, news and opinion
on nutrition, supplements, & health
